European Market Overview for Diabetes Monitoring, Treatment and Drug Delivery 2016 - MedView
The European diabetes diagnosis, treatment and drug delivery market increased in 2015 and growth is expected to persist over the forecast period. Market growth will be driven by the growing prevalence of diabetes in Europe and technological advancements made in certain segments, particularly insulin pumps and continuous glucose monitoring (CGM). Limitations to market growth include pricing pressure due to increased competition in the test strip and pen needle segments, as well as budgetary pressure to decrease diabetes expenditure of national healthcare organizations.
Diabetes mellitus is a multifaceted disease that yields various approaches in terms of diagnosis, treatment and drug delivery. Products for maintenance and treatment of diabetes can be of high volume and low cost or of relatively low volume and high cost.